Methods and compositions for improving oncolytic virus infection for nonpermissive cancers
AssigneeArizona Board of Regents on behalf of Arizona State University
InventorsDouglas Grant McFadden, Mohammed Masmudur Rahman
Life of this patent
Estimating the term…
Abstract
Disclosed herein are methods and compositions of treating cancer, comprising administrating to a subject with cancer a therapeutically effective amount of an oncolytic virus and a nucleocytoplasmic transport inhibitor. Further described herein are methods of converting a nonpermissive cancer cell to a permissive cancer cell and methods of killing a cancer cell by contacting the cancer cell with a therapeutically effective amount of an oncolytic vims and a nucleocytoplasmic transport inhibitor.
Claims7
A method of enhancing susceptibility of a cancer cell to infection by an oncolytic virus, comprising contacting the cancer cell to an oncolytic virus and a nucleocytoplasmic transport inhibitor, wherein the nucleocytoplasmic transport inhibitor is Leptomycin B.
A pharmaceutical composition comprising:
- a. an oncolytic virus, and
- b. a nucleocytoplasmic transport inhibitor, wherein the nucleocytoplasmic transport inhibitor is Leptomycin B.
Dependencies are inferred from the claim text.